Studies on bcl-2 protein in cultured lymphoid cells.
✍ Scribed by Agata Filip; Danuta Rożynkowa
- Publisher
- Elsevier Science
- Year
- 1994
- Tongue
- English
- Weight
- 525 KB
- Volume
- 18
- Category
- Article
- ISSN
- 1065-6995
No coin nor oath required. For personal study only.
✦ Synopsis
ABSTRACT
Bc1‐2 protein was analysed in cell cultures derived from non‐Hodgkin lymphomas and chronic lymphocytic leukaemia patients. The presence of bc1‐2 proto‐oncogene protein product has been demonstrated on cytospin preparations utilising immunochemical methods. The correlation between the expression of the bc1‐2 protein and the appearance of proliferation‐ or differentiation related figures was studied. The reported bc1‐2 up regulation in malignant lymphoid cells was confirmed in haemo‐ and lymphopoietic progenitor cells as well as in TPA/PHA activated peripheral blood lymphocytes. In comparison to neoplastic cells lower intensity of bc1‐2 positive staining in freshly isolated cells from non‐leukaemic tissue was observed.
📜 SIMILAR VOLUMES
The presence of BCL-2gene rearrangement has been detected also in cellular populations lacking the t(14;18) chromosomal translocation, such as B-lineage acute lymphobiastic leukemia (ALL) cells. It has been reported that overexpression of BCL-2 is related to resistance to glucocorticoid-induced apop
## Abstract An increase in the permeability of the outer mitochondrial membrane is central to apoptotic cell death, since it leads to the release of several apoptogenic factors, such as cytochrome c and Smac/Diablo, into the cytoplasm that activate downstream death programs. During apoptosis, the m